Serum PD-1 levels measured by ELISA using Nivolumab increased in advanced RCC patients: novel approach to develop companion diagnostics for antibody therapy

Kosuke Mizutani; Kengo Horie; Taku Kato; Keita Nakane; Kyojiro Kawakami; Yasunori Fujita; Masafumi Ito

doi:10.1007/s00432-018-2806-2

Serum PD-1 levels measured by ELISA using Nivolumab increased in advanced RCC patients: novel approach to develop companion diagnostics for antibody therapy

Kosuke Mizutani
, Kengo Horie
, Taku Kato
, Keita Nakane
, Kyojiro Kawakami
, Yasunori Fujita
, Masafumi Ito

研究成果: ジャーナルへの寄稿 › Letter › 査読

本文言語	英語
ページ（範囲）	1661-1663
ページ数	3
ジャーナル	Journal of Cancer Research and Clinical Oncology
巻	145
号	6
DOI	https://doi.org/10.1007/s00432-018-2806-2
出版ステータス	出版済み - 01-06-2019
外部発表	はい

All Science Journal Classification (ASJC) codes

腫瘍学
癌研究

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.1007/s00432-018-2806-2

他のファイルとリンク

引用スタイル

@article{87327068fed24672a1876a0541736cd8,

title = "Serum PD-1 levels measured by ELISA using Nivolumab increased in advanced RCC patients: novel approach to develop companion diagnostics for antibody therapy",

author = "Kosuke Mizutani and Kengo Horie and Taku Kato and Keita Nakane and Kyojiro Kawakami and Yasunori Fujita and Masafumi Ito",

note = "Funding Information: Funding This study was funded by Gifu University Graduate School of Medicine Research Grant Program and JSPS KAKENHI Grant Number JP16K20130, Japan.",

year = "2019",

month = jun,

day = "1",

doi = "10.1007/s00432-018-2806-2",

language = "English",

volume = "145",

pages = "1661--1663",

journal = "Journal of Cancer Research and Clinical Oncology",

issn = "0171-5216",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "6",

}

Serum PD-1 levels measured by ELISA using Nivolumab increased in advanced RCC patients: novel approach to develop companion diagnostics for antibody therapy. / Mizutani, Kosuke; Horie, Kengo; Kato, Taku その他.
In: Journal of Cancer Research and Clinical Oncology, Vol. 145, No. 6, 01.06.2019, p. 1661-1663.

研究成果: ジャーナルへの寄稿 › Letter › 査読

TY - JOUR

T1 - Serum PD-1 levels measured by ELISA using Nivolumab increased in advanced RCC patients

T2 - novel approach to develop companion diagnostics for antibody therapy

AU - Mizutani, Kosuke

AU - Horie, Kengo

AU - Kato, Taku

AU - Nakane, Keita

AU - Kawakami, Kyojiro

AU - Fujita, Yasunori

AU - Ito, Masafumi

N1 - Funding Information: Funding This study was funded by Gifu University Graduate School of Medicine Research Grant Program and JSPS KAKENHI Grant Number JP16K20130, Japan.

PY - 2019/6/1

Y1 - 2019/6/1

UR - https://www.scopus.com/pages/publications/85057748784

UR - https://www.scopus.com/pages/publications/85057748784#tab=citedBy

U2 - 10.1007/s00432-018-2806-2

DO - 10.1007/s00432-018-2806-2

M3 - Letter

C2 - 30515569

AN - SCOPUS:85057748784

SN - 0171-5216

VL - 145

SP - 1661

EP - 1663

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

IS - 6

ER -